Edition:
United States

Penumbra Inc (PEN.N)

PEN.N on New York Stock Exchange

142.35USD
4:00pm EDT
Change (% chg)

$-0.19 (-0.13%)
Prev Close
$142.54
Open
$142.37
Day's High
$144.26
Day's Low
$140.81
Volume
48,163
Avg. Vol
94,195
52-wk High
$167.30
52-wk Low
$82.65

Chart for

About

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address... (more)

Overall

Beta: --
Market Cap(Mil.): $4,625.40
Shares Outstanding(Mil.): 34.38
Dividend: --
Yield (%): --

Financials

  PEN.N Industry Sector
P/E (TTM): 116.43 38.68 32.14
EPS (TTM): 1.16 -- --
ROI: 11.97 13.89 12.83
ROE: 11.52 16.74 14.95

BRIEF-Penumbra, Inc. Reports Qtrly Earnings Per Share $0.15

* PENUMBRA, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 08 2018

Competitors

  Price Chg
Terumo Corp (4543.T) ¥6,520 +10.00
Johnson & Johnson (JNJ.N) $139.46 +2.90
Medtronic PLC (MDT.N) $97.29 +0.74
Stryker Corporation (SYK.N) $176.23 +1.13
Boston Scientific Corporation (BSX.N) $38.00 -0.11

Earnings vs. Estimates